Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model

Zhongxiuzi Gao1, Jinhua Zheng, Bin Yang

  • 1Laboratory of Sono- and Photo-theranostic Technologies, Harbin Institute of Technology, Harbin 150080, China.

Cancer Letters
|February 14, 2013
PubMed

Insights

Sonodynamic therapy (SDT) inhibits tumor growth by suppressing new blood vessel formation (angiogenesis). This study reveals SDT

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cancer Research

Background:

  • Sonodynamic therapy (SDT) primarily studied for direct tumor cell cytotoxicity.
  • The impact of SDT on the tumor microenvironment, particularly angiogenesis, is largely unexplored.

Purpose of the Study:

  • To investigate the effects of SDT on angiogenesis and its contribution to anti-tumor activity.

Main Methods:

  • In vitro assays assessing endothelial cell proliferation, migration, invasion, and tube formation.
  • In vivo studies using a tumor xenograft mouse model.
  • Ultrastructural analysis of tumor microvasculature.

Main Results:

  • SDT significantly inhibited endothelial cell functions crucial for blood vessel development.
  • Tumor growth, intratumoral vascularity, and VEGF expression were markedly reduced by SDT in vivo.
  • Ultrastructural examination revealed damage to tumor microvasculature post-SDT.

Conclusions:

  • SDT effectively inhibits tumor-associated neovascularization.
  • Suppression of angiogenesis is a key mechanism underlying the anti-tumor efficacy of SDT.

Related Concept Videos